ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 273

$1.23M Total Retail Price of All Prescriptions

Rank: 4 out of 273

1,482 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,482 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

4% of this provider’s 1,482 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 18,599 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
BISOPROLOL FUMARATE 2,147 1,827 10 1 45
CARVEDILOL 1,388 1,126 2 3
TIKOSYN 1,288 1,172 10 3 69
WARFARIN SODIUM 792 706 4 7
DILTIAZEM ER 782 706 10 5 66
AMLODIPINE BESYLATE 764 653 6 2
SOTALOL 753 677 10 7 27
BENAZEPRIL HCL 654 580 8 35
FUROSEMIDE 611 523 9 5
DILTIAZEM 24HR ER 593 527 10 10 49
LEVOTHYROXINE SODIUM 516 459 11 25
DILTIAZEM 24HR CD 484 427 10 12 62
LISINOPRIL 451 384 13 4
TRIAMTERENE-HCTZ 439 371 14 53
FLECAINIDE ACETATE 435 406 10 15 71
LOSARTAN POTASSIUM 422 363 16 19
VERAPAMIL ER 407 361 17 64
SIMVASTATIN 373 358 18 6
MULTAQ 361 341 10 19 52
TRANDOLAPRIL 334 278 10 20 109
DIOVAN 312 281 21 21
POTASSIUM CHLORIDE 281 220 22 18
CLOPIDOGREL 267 247 23 9
ISOSORBIDE MONONITRATE ER 258 226 24 13
AMIODARONE HCL 214 196 25 23
PRAVASTATIN SODIUM 188 173 26 11
PLAVIX 187 176 27 12
DIGOXIN 168 109 28 15
OMEPRAZOLE 156 122 29 33
BENICAR 155 142 30 88
PRADAXA 152 151 31 22
METOPROLOL SUCCINATE 138 97 32 1
ATENOLOL 135 107 33 17
SYNTHROID 128 119 34 90
ATORVASTATIN CALCIUM 117 103 35 8
XARELTO 117 101 35 61
PRAZOSIN HCL 116 116 37 200
HYDROCHLOROTHIAZIDE 103 102 38 16
RAMIPRIL 94 91 39 24
NEXIUM 90 73 40 42
ENALAPRIL MALEATE 90 56 40 31
CARTIA XT 90 82 40 101
SPIRONOLACTONE 89 80 43 20
BYSTOLIC 89 63 43 26
TRICOR 88 88 45 63
FENOFIBRATE 86 63 46 34
PROPAFENONE HCL 82 54 47 57
ESCITALOPRAM OXALATE 82 71 47 86
DILT-XR 81 81 49 215
BISOPROLOL-HYDROCHLOROTHIAZIDE 70 64 50 84
CITALOPRAM HBR 68 68 51 77
SERTRALINE HCL 67 54 52 81
AMITRIPTYLINE HCL 67 66 R 52 98
FLUDROCORTISONE ACETATE 66 43 54 146
ALLOPURINOL 65 46 55 79
EXFORGE 62 40 56 82
CLONIDINE HCL 61 47 57 32
FOSINOPRIL SODIUM 59 35 58 112
FAMOTIDINE 59 59 58 91
TAMSULOSIN HCL 58 41 60 102
ACETAMINOPHEN-CODEINE 57 43 S3 61 164
DIOVAN HCT 53 47 62 58
PANTOPRAZOLE SODIUM 52 40 63 41
ZOLPIDEM TARTRATE 50 50 64 59
KLOR-CON M20 50 49 64 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.